Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar 13;10(3):e2320.
doi: 10.7759/cureus.2320.

A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases

Affiliations
Case Reports

A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases

Julianna Sienna et al. Cureus. .

Abstract

Sinonasal undifferentiated carcinoma (SNUC) is a rare aggressive neoplasm arising in the nasal cavity and paranasal sinuses. We report a unique case of an 80-year-old man who presented with a locally advanced SNUC involving the ethmoid, sphenoid, and maxillary sinuses and bilateral lymph nodes, clinical T4N2M0. Given his age and the initial extent of his primary tumour, he was treated with neoadjuvant chemotherapy followed by chemoradiation with a split course of 50 Gray (Gy) in 40 fractions delivered twice a day. Four months after his treatments, he developed a recurrence at the left lower eyelid and left frontal sinus, intrabdominal metastases, and a left cerebellar metastasis. A single fraction of 22 Gy was delivered to the cerebellar lesion using stereotactic radiosurgery. He survived 17 months from the initial presentation. We review the available literature regarding treatment of brain metastases and use of hyperfractionated radiotherapy in this rare head and neck cancer.

Keywords: hyperfractionated radiotherapy; induction chemotherapy; palliative radiotherapy; radiosurgery; sinonasal undifferentiated carcinoma; snuc; split course radiotherapy; stereotactic radiosurgery.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Pre-treatment magnetic resonance imaging (MRI)
Clockwise from top left: coronal T1 with gadolinium, axial T1, and sagittal T2
Figure 2
Figure 2. Histologic stains
From left to right: B-cell lymphoma antigen 2 (BCL-2), Ki-67, and cytokeratin 7 (CK7)

References

    1. Reiersen DA, Pahilan ME, Devaiah AK. Otolaryngol Head Neck Surg. Vol. 147. Surgery: 2012. Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma; pp. 7–14. - PubMed
    1. Xu CC, Dziegielewski PT, Mcgaw WT, Seikaly H. J Otolaryngol Head Neck Surg. Vol. 42. Surgery: 2013. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review; p. 2. - PMC - PubMed
    1. Gorelick J, Ross D, Marentette L, Blaivas M. Neurosurgery. Vol. 47. Neurosurgery; 2000. Sinonasal undifferentiated carcinoma: case series and review of the literature; pp. 750–754. - PubMed
    1. Pitman KT, Costantino PD, Lassen LF. Skull Base Surg. Vol. 5. Surgery: 1995. Sinonasal undifferentiated carcinoma: current trends in treatment; pp. 269–272. - PMC - PubMed
    1. Rischin D, Porceddu S, Peters L, et al. Head Neck. Vol. 26. Neck: 2004. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma; pp. 435–441. - PubMed

Publication types

LinkOut - more resources